Table 3. Muscle-Damage Biomarkers, Total Antioxidant Status (TAS) and Catalase Activity Before and Immediately After an Incremental Event (VAMEVAL test) and a Supra-Maximal Exhausting Race (Limited-Time Test) in Sedentary Subjects (SS), Long-Distance Runners (LDR), and Middle-Distance Runners (MDR) a.
| Variables | VAMEVAL Test | Limited-Time Test | ||
|---|---|---|---|---|
| Before | After | Before | After | |
| Myoglobin, µg.L-1 | ||||
| SS | 51 ± 16 | 349 ± 106 b | 73 ± 27 | 359 ± 124 b,c |
| LDR | 76 ± 11 | 344 ± 190 b | 92 ± 31 | 365 ± 145 d,c |
| MDR | 58 ± 15 | 346 ± 243 b | 87 ± 29 | 292 ± 142 b,e |
| CK, U.L -1 | ||||
| SS | 149 ± 14 | 198 ± 16 b | 153 ± 33 | 169 ± 43 |
| LDR | 154 ± 34 | 182 ± 46 b | 162 ± 47 | 174 ± 61 |
| MDR | 150 ± 35 | 202 ± 85 b | 166 ± 45 | 177 ± 57 |
| LDH, U.L -1 | ||||
| SS | 281 ± 59 | 396 ± 82 | 301 ± 61 | 535 ± 98 d,c,f |
| LDR | 363 ± 48 | 382 ± 87 | 378 ± 66 | 501 ± 80 b |
| MDR | 372 ± 50 | 397 ± 86 | 379 ± 43 | 445 ± 64 b |
| TAS, mmoles.L -1 | ||||
| SS | 1.42 ± 0.42 | 1.38 ± 0.34 | 1.4 ± 0.61 | 1.29 ± 0.56 |
| LDR | 1.58 ± 0.28 | 1.37 ± 0.93 | 1.52 ± 0.17 | 1.19 ± 0.31 b |
| MDR | 1.76 ± 0.31 | 1.06 ± 0.27 b | 1.54 ± 0.82 | 1.62 ± 0.98 |
| Catalase activity, U.mL -1 | ||||
| SS | 2.62 ± 0.42 | 2.52 ± 0.33 | 2.53 ± 0.54 | 2.49 ± 0.33 |
| LDR | 2.95 ± 0.44 | 1.98 ± 0.11 b | 2.75 ± 0.62 | 2.88 ± 0.19 |
| MDR | 2.56 ± 0.18 | 2.45±0.48 | 2.49 ± 0.27 | 1.89 ± 0.08 |
a Values are presented as mean ± SD.
b P < 0.05.
c differ significantly to MDR.
d P < 0.01 compared to baseline.
e Differ significantly to the other event.
f Differ significantly to LDR.